Found: 36
Select item for more details and to access through your institution.
Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 4, p. E95, doi. 10.1002/ajh.26084
- By:
- Publication type:
- Article
Increased endothelial uptake of paclitaxel as a potential mechanism for its antiangiogenic effects: Potentiation by Cox-2 inhibition.
- Published in:
- International Journal of Cancer, 2005, v. 113, n. 3, p. 490, doi. 10.1002/ijc.20595
- By:
- Publication type:
- Article
Combined PARP and HSP90 inhibition: preclinical and Phase 1 evaluation in patients with advanced solid tumours.
- Published in:
- British Journal of Cancer, 2022, v. 126, n. 7, p. 1027, doi. 10.1038/s41416-021-01664-8
- By:
- Publication type:
- Article
Combined PARP and HSP90 inhibition: preclinical and Phase 1 evaluation in patients with advanced solid tumours.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Pharmacokinetics of ecteinascidin 743 administered as a 24-h continuous intravenous infusion to adult patients with soft tissue sarcomas: associations with clinical characteristics, pathophysiological variables and toxicity.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Phase I clinical trial of 7-cyanoquinocarcinol (DX-52-1) in adult patients with refractory solid malignancies.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Plasma pharmacokinetics and bioavailability of 1-(2-chloroethyl)-3-sarcosinamide-1-nitrosourea after intravenous and oral administration to mice and dogs.
- Published in:
- 2001
- By:
- Publication type:
- journal article
A phase I clinical and pharmacokinetic study of the dolastatin analogue cemadotin administered as a 5-day continuous intravenous infusion.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Multicenter Phase II Study of Tivozanib (AV-951) and Everolimus (RAD001) for Patients With Refractory, Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2013, v. 18, n. 4, p. 377, doi. 10.1634/theoncologist.2012-0378
- By:
- Publication type:
- Article
Blood-brain barrier disruption and delivery of irinotecan in a rat model using a clinical transcranial MRI-guided focused ultrasound system.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-65617-6
- By:
- Publication type:
- Article
Pharmacokinetic Factors Contribute to the Inverse Relationship between Luteinizing Hormone and Body Mass Index in Polycystic Ovarian Syndrome.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2007, v. 92, n. 4, p. 1347, doi. 10.1210/jc.2006-2716
- By:
- Publication type:
- Article
Disappearance of Endogenous Luteinizing Hormone Is Prolonged in Postmenopausal Women.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1999, v. 84, n. 2, p. 688, doi. 10.1210/jcem.84.2.5433
- By:
- Publication type:
- Article
Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia.
- Published in:
- Pediatric Blood & Cancer, 2010, v. 54, n. 2, p. 199, doi. 10.1002/pbc.22225
- By:
- Publication type:
- Article
Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors.
- Published in:
- Pediatric Blood & Cancer, 2009, v. 52, n. 2, p. 169, doi. 10.1002/pbc.21873
- By:
- Publication type:
- Article
Efficacy and toxicity of the antisense oligonucleotide aprinocarsen directed against protein kinase C-α delivered as a 21-day continuous intravenous infusion in patients with recurrent high-grade astrocytomas.
- Published in:
- Neuro-Oncology, 2005, v. 7, n. 1, p. 32, doi. 10.1215/S1152851703000353
- By:
- Publication type:
- Article
Phase 2 study of weekly irinotecan in adults with recurrent malignant glioma: Final report of NABTT 97-11.
- Published in:
- Neuro-Oncology, 2004, v. 6, n. 1, p. 21, doi. 10.1215/S1152851703000218
- By:
- Publication type:
- Article
Metabolic Inhibition of Galectin-1-Binding Carbohydrates Accentuates Antitumor Immunity.
- Published in:
- Journal of Investigative Dermatology, 2012, v. 132, n. 2, p. 410, doi. 10.1038/jid.2011.335
- By:
- Publication type:
- Article
Phase 1 study of the HSP90 inhibitor onalespib in combination with AT7519, a pan-CDK inhibitor, in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 6, p. 815, doi. 10.1007/s00280-020-04176-z
- By:
- Publication type:
- Article
Phase 1 study of N(1),N(11)diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Phase 1 study of <i>N</i><sup>1</sup>,<i>N</i><sup>11</sup>-diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1305, doi. 10.1007/s00280-013-2293-8
- By:
- Publication type:
- Article
Phase I clinical trial of the farnesyltransferase inhibitor BMS-214662 administered as a weekly 24 h continuous intravenous infusion in patients with advanced solid tumors.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Intratumoral concentrations of imatinib after oral administration in patients with glioblastoma multiforme.
- Published in:
- Journal of Neuro-Oncology, 2010, v. 97, n. 2, p. 241, doi. 10.1007/s11060-009-0008-0
- By:
- Publication type:
- Article
A dose finding clinical trial of cabozantinib (XL184) administered in combination with abiraterone acetate in metastatic castration‐resistant prostate cancer.
- Published in:
- Prostate, 2018, v. 78, n. 14, p. 1053, doi. 10.1002/pros.23662
- By:
- Publication type:
- Article
Phase 1b clinical trial of ado-trastuzumab emtansine and ribociclib for HER2-positive metastatic breast cancer.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00311-y
- By:
- Publication type:
- Article
Multimodal platform for assessing drug distribution and response in clinical trials.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 1, p. 64, doi. 10.1093/neuonc/noab197
- By:
- Publication type:
- Article
Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 6, p. 845, doi. 10.1093/neuonc/nox020
- By:
- Publication type:
- Article
Feasibility, phase I, and phase II studies of tandutinib, an oral platelet-derived growth factor receptor-β tyrosine kinase inhibitor, in patients with recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 567, doi. 10.1093/neuonc/now185
- By:
- Publication type:
- Article
NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 4, p. 490, doi. 10.1093/neuonc/nos322
- By:
- Publication type:
- Article
Phase I study of terameprocol in patients with recurrent high-grade glioma.
- Published in:
- Neuro-Oncology, 2012, v. 14, n. 4, p. 511
- By:
- Publication type:
- Article
A Phase I study of bortezomib plus irinotecan in patients with advanced solid tumors.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 10, p. 2482, doi. 10.1002/cncr.22264
- By:
- Publication type:
- Article
Phase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinomaPreliminary results were presented at the Thirty‐Seventh Annual Meeting of the American Society of Clinical Oncology, San Francisco, California, May 12–15, 2001.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 7, p. 1418, doi. 10.1002/cncr.21312
- By:
- Publication type:
- Article
Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma.
- Published in:
- 2003
- By:
- Publication type:
- journal article
A Phase I study of 9-nitrocamptothecin given concurrently with capecitabine in patients with refractory, metastatic solid tumors.
- Published in:
- Cancer (0008543X), 2003, v. 97, n. 1, p. 148, doi. 10.1002/cncr.11038
- By:
- Publication type:
- Article
A Phase I-II study of 96-hour infusional topotecan and paclitaxel for patients with recurrent Müllerian tumors.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Chemical genetics identify eIF2? kinase heme-regulated inhibitor as an anticancer target.
- Published in:
- Nature Chemical Biology, 2011, v. 7, n. 9, p. 610, doi. 10.1038/nchembio.613
- By:
- Publication type:
- Article